TO BE RESCHEDULED (Covid-19 situation) - BioE Colloquia Series talk
Event details
Date | 30.03.2020 |
Hour | 12:15 |
Speaker | Prof. Jacob Corn, ETHZ |
Location | |
Category | Conferences - Seminars |
WEEKLY BIOENGINEERING COLLOQUIA SERIES
(sandwiches served)
Abstract:
Bio:
acob Corn is the Professor of Genome Biology at the ETH Zurich. His research aims to better understand and treat disease through next-generation genome editing technologies. Jacob’s career has bridged academia and industry, working in therapeutic areas that include infectious disease, neurobiology, and oncology. His research takes a multidisciplinary approach, combining cellular biochemistry, functional genomics, computational biology, bioengineering, and biophysics. Jacob’s graduate studies at the University of California, Berkeley explored how cells replicate and protect their genomes. His postdoctoral work at the University of Washington computationally designed protein inhibitors from scratch. Jacob began his independent research career as a group leader at Genentech, where his lab discovered biological mechanisms for challenging therapeutic targets. Jacob then moved back to academia as the founding Scientific Director of the Innovative Genomics Institute and faculty at UC Berkeley.
(sandwiches served)
Abstract:
Bio:
acob Corn is the Professor of Genome Biology at the ETH Zurich. His research aims to better understand and treat disease through next-generation genome editing technologies. Jacob’s career has bridged academia and industry, working in therapeutic areas that include infectious disease, neurobiology, and oncology. His research takes a multidisciplinary approach, combining cellular biochemistry, functional genomics, computational biology, bioengineering, and biophysics. Jacob’s graduate studies at the University of California, Berkeley explored how cells replicate and protect their genomes. His postdoctoral work at the University of Washington computationally designed protein inhibitors from scratch. Jacob began his independent research career as a group leader at Genentech, where his lab discovered biological mechanisms for challenging therapeutic targets. Jacob then moved back to academia as the founding Scientific Director of the Innovative Genomics Institute and faculty at UC Berkeley.
Practical information
- Informed public
- Free
Organizer
- Prof. Patrick Barth, EPFL
Contact
- Institute of Bioengineering (IBI), Christina Mattsson